Plasmakinetic enucleation and resection of the prostate by divided into three parts and blocking blood flow in advance
10.3969/j.issn.1007-1989.2016.08.003
- VernacularTitle:经尿道等离子血供预断式前列腺三分区法剜切术的临床观察
- Author:
Wansong CAI
;
Liping WEN
- Keywords:
benign prostatic hyperplasia;
plasmakinetic resection of the prostate;
plasmakinetic enucleation and resection of the prosatate by divided into three parts and blocking blood flow in advance
- From:
China Journal of Endoscopy
2016;22(8):9-13
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the efficacy and safety of plasmakinetic enucleation and resection of the prostate by divided into three parts and blocking blood flow in advance (PKERPDPB). Methods 158 patients with BPH were randomly divided two groups: 81 patients treated by plasmakinetic enucleation and resection of the prostate by divided into three parts and blocking blood flow in advance (PKERPDPB), 77 patients treated by plasmakinetic resection of the prostate (PKRP). All patients were evaluated preoperatively and at 1, 6, 12 months after surgery by IPSS, QOL, Qmax and PVR. Operation time, resected adenoma weight, catheterization time, hospital stay and complications were documented. Results There were no significant differences in preoperative parameters. The resected adenoma weight in the PKERPADPB group was heavier than that in the PKRP group, the difference was significant. Compared with PKRP, PKERPDPB required a longer operation time, but resulted in less hemoglobin decrease, less catheterization time and hospital time. During the 1, 6, 12 months of follow-up, there was no significant difference in Qmax, IPSS, PVR and QOL between the groups. Conclusion PKERPDPB was statistically superior to PKRP in blood loss, catheterization time, hospital stay but inferior in operation time. It was a safe and effective treatment for BPH.
